News

Filter

1 to 9 of 46 results

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

19-02-2015

Positive data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first…

BiosimilarsBiotechnologyGastro-intestinalsHospiraInflectraJohnson & JohnsonMerck & CoRemicadeResearch

Effective new cholesterol treatments will come at great cost to health care system, says CVS

Effective new cholesterol treatments will come at great cost to health care system, says CVS

18-02-2015

The new class of cholesterol drugs could provide successful treatment to millions of Americans, but the…

BiotechnologyCVS HealthGastro-intestinalsMarkets & MarketingPricingUSA

TiGenix and Lonza sign agreement for the manufacture of Crohn’s disease treatment

TiGenix and Lonza sign agreement for the manufacture of Crohn’s disease treatment

12-02-2015

Swiss CMO Lonza and Belgian cell therapy firm TiGenix have agreed that Lonza will manufacture material…

BiotechnologyGastro-intestinalsLicensingLonzaTiGenixUSA

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

29-01-2015

French biotech company TxCell has received the latest 1 million-euro milestone payment ($1.13 million)…

BiotechnologyGastro-intestinalsLicensingOvaSaveResearchTxCell

Vedanta collaborates with Janssen on IBD drug candidate VE202

13-01-2015

US microbiome company Vedanta Biosciences has signed a license agreement with Janssen Biotech for Vedanta's…

BiotechnologyGastro-intestinalsJanssen BiotechJohnson & JohnsonLicensingResearchVE202Vedanta Biosciences

Isis Pharma teams up with Janssen on autoimmune disorders in the GI tract

05-01-2015

Isis Pharmaceuticals has entered into a global collaboration with Janssen Biotech, a unit of US health…

BiotechnologyGastro-intestinalsIsis PharmaceuticalsJanssen BiotechJohnson & JohnsonLicensingResearch

TxCell and Ferring collaborate with Trizell on lead product Ovasave

TxCell and Ferring collaborate with Trizell on lead product Ovasave

04-01-2015

French biotech firm TxCell on Friday announced a further enhancement to the development of its lead product…

BiotechnologyFerring PharmaceuticalsGastro-intestinalsLicensingOvaSaveResearchTrizell HoldingTxCell

NICE opens consultation on Millennium’s Crohn’s drug Entyvio

23-12-2014

In draft guidance issued today, UK health costs watchdog the National Institute for Health and Care Excellence…

BiotechnologyEntyvioGastro-intestinalsMillennium PharmaceuticalsPricingRegulationTakeda PharmaceuticalUK

1 to 9 of 46 results

COMPANY SPOTLIGHT

Menarini

Back to top